Insider Shareholders with Direct Ownership of Verona Pharma PLC (VRNA)
This section provides a comprehensive overview of the insiders with direct ownership of Verona Pharma PLC (VRNA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Verona Pharma plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Claire Poll
General Counsel |
1,178,800 | 2,522,376 | 2,017,391 $216 Million | 22 |
Oct 20, 2023
Added 9.02%
|
|
David R Ebsworth
Director |
951,360 | 1,041,499 | 880,499 $94.1 Million | 13 |
Aug 01, 2025
Reduced 0.22%
|
|
Vikas Sinha
Director |
276,000 | 370,680 | 0 $0 | 10 |
Oct 07, 2025
Reduced 100.0%
|
|
Christina Ackermann
Director |
177,880 | 177,880 | 0 $0 | 7 |
Oct 07, 2025
Reduced 100.0%
|
|
Mark W Hahn
Chief Financial Officer |
10,839,600 | 29,815,008 | 0 $0 | 70 |
Oct 07, 2025
Reduced 100.0%
|
|
Kathleen A. Rickard
Chief Medical Officer |
3,130,000 | 6,227,148 | 0 $0 | 50 |
Oct 07, 2025
Reduced 100.0%
|
|
David Zaccardelli
President and CEO |
11,463,552 | 31,028,688 | 0 $0 | 72 |
Oct 07, 2025
Reduced 100.0%
|
|
Martin Edwards
Director |
129,736 | 266,512 | 0 $0 | 7 |
Oct 07, 2025
Reduced 100.0%
|
|
Anders Ullman
Director |
96,000 | 453,712 | 0 $0 | 5 |
Oct 07, 2025
Reduced 100.0%
|
|
Mahendra Shah
Director |
96,000 | 190,560 | 0 $0 | 6 |
Oct 07, 2025
Reduced 100.0%
|
|
Kenneth Cunningham
Director |
96,000 | 188,800 | 0 $0 | 6 |
Oct 07, 2025
Reduced 100.0%
|
|
Lisa Deschamps
Director |
212,000 | 212,000 | 0 $0 | 9 |
Oct 07, 2025
Reduced 100.0%
|
|
James Aloysius Brady
Director |
96,000 | 96,000 | 0 $0 | 4 |
Oct 07, 2025
Reduced 100.0%
|
|
Michael Austwick
Director |
96,000 | 96,000 | 0 $0 | 4 |
Oct 07, 2025
Reduced 100.0%
|
|
Andrew Fisher
General Counsel |
1,585,001 | 1,585,007 | 0 $0 | 14 |
Oct 07, 2025
Reduced 100.0%
|